Trial Details
COMPLETEDBasic Information
| Clinical ID | c4601 |
|---|---|
| Identifier | NCT00269438 |
| Trial Title | New Tablet Formulation and Dosing Regimen of Balsalazide Disodium in Mildly to Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: 5 ASA, enemas, suppositories, corticosteroids |
Participant Information
| Sponsor | Bausch Health Americas, Inc. |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2005-12 |
|---|---|
| Primary Completion Date | 2007-03 |
| Completion Date | 2007-06 |